Author:
Bartels Sophia M.,Phan Huong T. T.,Hutton Heidi E.,Nhan Do T.,Sripaipan Teerada,Chen Jane S.,Rossi Sarah L.,Ferguson Olivia,Nong Ha T. T.,Nguyen Ngan T. K.,Giang Le Minh,Bui Hao T. M.,Chander Geetanjali,Sohn Hojoon,Kim Sol,Tran Ha V.,Nguyen Minh X.,Powell Byron J.,Pence Brian W.,Miller William C.,Go Vivian F.
Abstract
Abstract
Background
Evidence-based interventions (EBIs) often address normative behaviors. If a behavior is also common among clinicians, they may be skeptical about the necessity or effectiveness of an EBI. Alternatively, clinicians’ attitudes and behaviors may be misaligned, or they may lack the knowledge and self-efficacy to deliver the EBI. Several EBIs address unhealthy alcohol use, a common and often culturally acceptable behavior. But unhealthy alcohol use may be particularly harmful to people with HIV (PWH). Here, we present an implementation trial using an experiential implementation strategy to address clinicians’ knowledge, attitudes, and behaviors. Clinicians receive the experiential intervention before they begin delivering an evidence-based brief alcohol intervention (BAI) to PWH with unhealthy alcohol use.
Methods
Design: In this hybrid type 3 implementation-effectiveness cluster randomized controlled trial, ART clinics (n = 30) will be randomized 1:1 to facilitation, a flexible strategy to address implementation barriers, or facilitation plus the experiential brief alcohol intervention (EBAI). In the EBAI arm, clinicians, irrespective of their alcohol use, will be offered the BAI as experiential learning. EBAI will address clinicians’ alcohol-related attitudes and behaviors and increase their knowledge and confidence to deliver the BAI.
Participants: ART clinic staff will be enrolled and assessed at pre-BAI training, post-BAI training, 3, 12, and 24 months. All PWH at the ART clinics who screen positive for unhealthy alcohol use will be offered the BAI. A subset of PWH (n = 810) will be enrolled and assessed at baseline, 3, and 12 months.
Outcomes: We will compare implementation outcomes (acceptability, fidelity, penetration, costs, and sustainability) and effectiveness outcomes (viral suppression and alcohol use) between the two arms. We will assess the impact of site-level characteristics on scaling-up the BAI. We will also evaluate how experiencing the BAI affected clinical staff’s alcohol use and clinic-level alcohol expectations in the EBAI arm.
Discussion
This trial contributes to implementation science by testing a novel strategy to implement a behavior change intervention in a setting in which clinicians themselves may engage in the behavior. Experiential learning may be useful to address normative and difficult to change lifestyle behaviors that contribute to chronic diseases.
Trial Registration
NCT06358885 (04/10/2024), https://clinicaltrials.gov/study/NCT06358885.
Funder
National Institute on Alcohol Abuse and Alcoholism
National Institute on Drug Abuse
Center for AIDS Research, University of North Carolina at Chapel Hill
National Institute of Mental Health and Neurosciences
National Heart, Lung, and Blood Institute
National Cancer Center
Publisher
Springer Science and Business Media LLC